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Abstract
Chemical Biology is a relatively new field, and as such is not yet simply or succinctly defined. It
includes such a wide range of fundamental problems that this commentary could only include just
a few snapshots of potential areas of interest. Overarching themes and selected recent successes
and ideas in chemical biology are described to illustrate broadly the scope of the field, but should
not be taken as exhaustive. The Chemical Biology Section of Chemistry Central Journal is pleased
to receive manuscripts describing research into all and any aspects of the subject.
Background
One always expects a commentary of this sort to begin
with a clear and succinct definition of the scope and
boundaries of the topic under discussion. Unfortunately,
when asked to define Chemical Biology, most researchers
seem to be lost for an apt description. In fact, a brief sur-
vey of colleagues led to a consensus of "Chemical Biology,
like good taste, is somewhat hard to pin down, but you
know it when you see it".
Perhaps some of the problem lies in the sheer range of
topics that fall under the umbrella of the discipline. A
small sample of the literature being produced by Chemi-
cal Biology institutes and departments around the world
included articles ranging from enzymology to medicinal
chemistry, and from structural biology to single cell pro-
teomics. The list of subject groups and departments col-
laborating on Chemical Biology projects is equally varied,
reflecting a tremendous diversity of specialisations con-
tributing to the field.
Some attempts at definition have focused on what Chem-
ical Biology is not. It is not a service for biologists with
chemists acting as an upgraded version of the Sigma cata-
logue. (One biologist who clearly disagreed with this view
once asked me "how many new compounds can you
make in a week?") Equally it is not about a remora-like
relationship where one scavenges ever higher impact fac-
tor articles by adding some biological data to what was a
rather lightweight synthetic paper. This field should repre-
sent the best and brightest and not the worst and most
mundane aspects of its predecessors.
Considering all this, a common underlying theme can be
discerned; collaboration. Collaborative partnerships have
made Chemical Biology into a subject in its own right. It
would be extraordinary for a single person to be enough
of a polymath to be at the forefront of both chemistry and
biology, and thus it is all too easy to do great chemistry
and weak biology or vice versa. However, where there is
sufficient inclination for collaborators to learn each
other's language and work on identifying the concepts
that underpin a meaningful conversation, two specialists
can work synergistically to address problems in a com-
pletely new way. It is this partnership, which allows cut-
ting edge chemical concepts and tools to be brought to
bear on previously impenetrable biological systems, that
is the essence of Chemical Biology. Perhaps becoming a
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great chemical biologist is more about finding the right
partner than finding yourself.
Whatever your view of Chemical Biology as a field, there
is a great deal of evidence that chemistry is uniquely
placed to increase our understanding of, and ability to
intervene in, biological processes. Unlike their biological
counterparts (principally antibodies and siRNA), syn-
thetic small molecules may be cell-permeable, easily
delivered at different doses with accurate quantitation and
selectable timing, and their specificity can be modified
simply. However, we have had to develop new synthetic
strategies in order to generate sufficiently selective and
active lead compounds. Equally new analytical tech-
niques with improved detectivity, sensitivity and selectiv-
ity have been required to cope with complex biological
systems. Methodological and technological advances have
thus been almost as important as the new targets they
have enabled us to investigate. I have therefore chosen to
outline examples of interesting methodological advances
and current targets separately. It is difficult to choose just
a few current examples of exciting Chemical Biology,
because recent achievements, like the subject matter, are
many and varied. The selected examples do not therefore
represent a comprehensive list, but are simply a selection
of my favourites across the spectrum of the field.
Discussion
Methodological advances
Chemical genetics
Chemical genetics, [1] which relies on selecting small
molecules for their ability to induce a biological pheno-
type or to interact with a particular gene product, is one of
the best examples of a methodological development in
lead generation. Forward (screening for phenotype) and
reverse (screening for activity against a selected protein)
chemical genetics, by combining medicinal chemistry,
biological screening and combinatorial synthesis tech-
niques, has enabled us to address previously intractable
problems. Since developments in synthetic methodology
tend to be incorporated into new library development,
and improvements in analytical and biological methodol-
ogy are applied to screening systems, chemical genetics
research often encapsulates the best of both chemistry and
biology.
Directed evolution
One of the most elegant examples of the extension of bio-
logical processes to ligand discovery is that of in vitro evo-
lution. One of the reasons why antibodies have such good
binding parameters is that in vivo they are subjected to
rounds of expansion, selection and mutation which allow
them to evolve with repeated exposure to the challenging
agent. This process of evolution of activity by selection
and mutation was first utilised ex vivo in phage display
technology [2] and later using yeast or bacteria as vectors.
This has been extended to in vitro techniques such as
ribosome display [3], a wholly cell-free system for the
directed evolution of peptides. Methods for the in vitro
generation and evolution of aptamers (RNA and DNA
sequences which bind specific targets) are also now well
established [4]. Stability and cell permeability remain a
problem, although such systems have been improved by
incorporating synthetic residues, or by undertaking post
selection modification. One particularly striking example
of the integration of aptamer evolution with chemical
modifications, utilised combinatorial chemistry tech-
niques during the selection process to generate a new moi-
ety which tightly binds the transactivational responsive
(TAR) element of HIV-1 [5].
Design, induction and adaptation of new catalysts
Chemical approaches to biological systems have not only
generated target-binding entities, but also novel catalysts.
Stable analogues of transition-states are routinely used to
generate antibodies which catalyse reactions of interest,
and these have been applied to drug activation, drug
detoxification, and synthetic chemistry [6]. Naturally
occurring enzymes have also been engineered to alter
their activities and specificities for use in synthetic, envi-
ronmental and medical applications [7]. Conversely,
wholly synthetic inorganic complexes have been used suc-
cessfully as artificial mimics of enzymes such as catalase
and superoxide dismutase [8,9].
Analytical methodology
There is a vast armament of traditional chemical analytical
techniques (both classical and instrumental) which may
be applied to the products of living systems. Experimental
design, engineering and computer processing develop-
ments have allowed us to examine complexes and struc-
tures of ever increasing molecular weight and complexity
with ever greater accuracy and resolution. Previously
unobservable non-covalent interactions have been
mapped, and the cross-talk between cellular (and extracel-
lular) components investigated. New phenomena in qua-
ternary structure and binding site topology are also being
reported.
However, we do still have some really challenging analyt-
ical problems that only just beginning to be addressed.
The phenotypic heterogeneity of supposedly identical
individual cells has proved a confounding problem for
molecular biologists. Standard biological techniques such
as western blotting and microarraying require large num-
bers of cells, and can only produce an average result for a
culture or tissue sample masking the intrinsic heterogene-
ity of populations of cells. Developments in miniaturisa-
tion and quantitative amplification methods are starting
to generate more quantitative and qualitative data fromChemistry Central Journal 2007, 1:5
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single cells. Equally, new non-destructive methods, partic-
ularly those which can be used in vivo, are opening up
whole new areas of research [10].
Current targets
Control of cell division
Some of the most notable breakthroughs have been made
in elucidating and intervening in the processes involved in
cell division. There has been intense activity in this area
not just because it is such a fundamental part of living sys-
tems, but also because of the potential for anti-cancer
applications. One of the first, and perhaps best known,
successes in this aspect of Chemical Biology is that of
Monastrol [1]. Monastrol was selected as a result of a phe-
notype-based screen to identify compounds which dis-
rupt the mitotic spindle during cell division. It was found
to act by specifically inhibiting the activity of the kinesin
Eg5, and has opened up a whole new aspect to cell cycle
research and enabled completely new modes of inhibiting
cell growth.
It should not be forgotten that the converse of uncon-
trolled cell division, cellular senescence, also represents an
important biological target. With every division there is an
increasing chance of cells entering cellular senescence,
and never dividing again. This is not only a problem in
terms of our ability to replace damaged tissues. In addi-
tion, cells which have entered senescence persist in tissue,
and take on an altered, deleterious phenotype which is
thought to contribute to ageing. Work which elucidates
replicative control pathways thus also has a high likeli-
hood of generating important information relating to the
ageing process, an area in which I have a particular inter-
est. The Chemical Biology of Ageing is really in its infancy,
but the current demographic shift towards an aged popu-
lation means that it is likely that this will represent one of
the most important areas for progress in the future.
Cellular activity modulation
Whilst there are many modes of cellular regulation, mem-
brane bound receptors represent an attractive target for
small molecule-mediated control of cellular activity
because of their accessibility. Small molecules which act
as receptor ligands or inhibitors have been used success-
fully for neurological problems such as bladder control
[11] and epilepsy [12], and for controlling smooth muscle
activity [13] although work continues on improving the
activity and selectivity over the drugs currently in use.
Other receptor targets, such as those controlling the
immune system and the induction of apoptosis have
really only been exploited using antibody and peptide lig-
ands, and successful synthetic modulators have yet to
appear. Alternative possibilities for the chemical regula-
tion of cellular processes including selective ion-channel
modulators [14] and sequence specific DNA binding mol-
ecules (which promote or inhibit the transcription of spe-
cific genes), [15] are also being investigated.
Another type of approach is to study the chemical interac-
tions between biological systems in their natural environ-
ment. Electrochemical methods have been used to
characterise the effects of naturally produced algal exu-
dates on the behaviour of other algae, [16] leading to the
discovery of some interesting new ligands which affect
growth rate and trace metal uptake.
Small biological molecule targets
Although natural products are popular as lead com-
pounds, there has been rather less research devoted to
small biological molecules as targets, and this remains a
relatively undeveloped area. One such example, the group
of compounds known as reactive oxygen and nitrogen
species (RONS), has been successfully targeted, with a
body of work devoted to antioxidants designed to prevent
damage by soaking up the radical by-products of respira-
tion. This approach has even been extended to inorganic
complexes which mimic the actions of the antioxidant
enzymes catalase and superoxide dismutase [8,9].
Conclusion
As can be seen from the few examples given, research in
Chemical Biology has a great deal of potential for improv-
ing our understanding of biological systems and thereby
improving everyday lives. This has been reflected in the
large number of new journals devoted to Chemical Biol-
ogy that have been launched in the last few years. So why
do I think that your research should be sent to this section
of our journal?
I have two reasons for believing that this is a good place to
publish. Firstly, Chemical Biology research covers such a
range of fundamental problems that its true impact can
only be felt in a journal with a wide and non-specialist
readership. A discipline built on collaboration cannot be
inward looking, however tempting that might be. As Sec-
tion Editor I will welcome manuscripts covering any
aspect of the subject given the broadest possible defini-
tion, as our journal is designed to have broad appeal.
The second reason relates to the advantages of online
open access publishing. In my experience, there are two
kinds of referee. The first considers themselves as a guard-
ian of the literature, charged to ensure that only the finest,
most earth-shattering research ever appears in the Journal
of the Lilliputian Chemical Society, Section B2 (abbreviated
reports). The second type simply looks for good solid sci-
ence with much less interest in whether the work will win
a Nobel prize. So why do we see these differences in
approach to reviewing essentially similar articles? I think
that the former is so prevalent because of the pressures ofChemistry Central Journal 2007, 1:5
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paper publishing. A journal usually only receives a fixed
income for each issue, be it 50 pages or 500 pages long,
each page printed has costs attached to it, and each issue
is limited in size by the printing process, so every article
must contribute to the chance of generating subscriptions.
This can lead to subtle, but sustained pressure on editors
and referees to be exclusive, rather than inclusive. In con-
trast, online open access publishing frees editors and refe-
rees from these constraints, since information storage is
relatively cheap and journal income is per article pub-
lished. This new style of journal gives us a much greater
freedom of action as an editorial board.
So, my editorial policy for the Chemical Biology section of
Chemistry Central Journal will be simply this: all bad sci-
ence will be rejected, all good science will be published,
and all Nobel prize-winning science will be gratefully
received. What better reason could there be for submitting
your manuscript here?
If you have any queries about submitting a Chemical Biol-
ogy research report, please feel free to contact me.
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